KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Current Assets (2016 - 2025)

Historic Current Assets for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $46.9 billion.

  • Pfizer's Current Assets rose 856.26% to $46.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $46.9 billion, marking a year-over-year increase of 856.26%. This contributed to the annual value of $50.4 billion for FY2024, which is 1621.17% up from last year.
  • Pfizer's Current Assets amounted to $46.9 billion in Q3 2025, which was up 856.26% from $43.7 billion recorded in Q2 2025.
  • In the past 5 years, Pfizer's Current Assets registered a high of $74.0 billion during Q4 2023, and its lowest value of $5.9 billion during Q4 2022.
  • Moreover, its 5-year median value for Current Assets was $46.9 billion (2025), whereas its average is $46.6 billion.
  • Its Current Assets has fluctuated over the past 5 years, first soared by 114767.36% in 2023, then plummeted by 4843.01% in 2024.
  • Quarter analysis of 5 years shows Pfizer's Current Assets stood at $59.7 billion in 2021, then decreased by 14.13% to $51.3 billion in 2022, then decreased by 15.46% to $43.3 billion in 2023, then grew by 16.21% to $50.4 billion in 2024, then dropped by 6.82% to $46.9 billion in 2025.
  • Its Current Assets was $46.9 billion in Q3 2025, compared to $43.7 billion in Q2 2025 and $45.9 billion in Q1 2025.